Cemalettin Demir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cemalettin Demir has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Erkan Kilinc
Department of Physiology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
2 shared publications - Yasemin Baranoglu Kilinc
Department of Pediatrics Gaziosmanpasa SUAM, University of Health Sciences İstanbul Türkiye
2 shared publications - Abdullah Sarı1 shared publication
- Aise Rumeysa Mazi
Department of Biophysics, Hamidiye Faculty of Medicine, University of Health Sciences
1 shared publication - Aycan Baş
Department of Biophysics, Faculty of Medicine Afyonkarahisar Health Sciences University Afyonkarahisar Türkiye
1 shared publication - Aziz Karaca
Department of Physiology, Faculty of Medicine Recep Tayyip Erdoğan University Rize Turkey
1 shared publication
Latest Publications
- 22 October 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (8)
Spinorphin Ameliorates Nitroglycerin‐Induced Migraine‐Like Responses and Trigeminovascular Neuroinflammation Potentially Through Opioid Receptor‐Mediated Mechanisms
Enhancement of endogenous opioid signaling through inhibition of enkephalin degradation has emerged as a potential strategy for pain control, yet its role in migraine remains unclear. This study investigated whether spinorphin, an endogenous inhibitor of multiple enkephalinases, attenuates trigeminovascular activation and migraine‐like responses in experimental migraine. Migraine‐like pain was induced in male Wistar rats by nitroglycerin. The effects of spinorphin were evaluated using periorbital and plantar von Frey tests, followed by assessment of c‐Fos levels in the trigeminal nucleus caudalis (TNC), calcitonin gene‐related peptide (CGRP) levels in the trigeminal ganglion (TG) and TNC, and meningeal mast cell degranulation. Opioid receptor involvement was examined using nalmefene. In complementary ex vivo hemiskull preparations, capsaicin‐evoked CGRP release was quantified, and the interaction between spinorphin and sumatriptan was investigated. Spinorphin dose‐dependently alleviated cephalic and extracephalic mechanical hypersensitivity, reduced c‐Fos levels, decreased CGRP concentrations in the TG and TNC, and inhibited meningeal mast cell degranulation. These protective effects were markedly attenuated by nalmefene, supporting the involvement of opioid receptor‐mediated mechanisms. In ex vivo preparations, spinorphin selectively reduced capsaicin‐induced CGRP levels in the superfusates without affecting basal CGRP levels, and this effect was abolished by nalmefene. Moreover, spinorphin enhanced the inhibitory effect of sumatriptan on capsaicin‐stimulated CGRP levels. Spinorphin attenuates behavioral, neurochemical, and neuroinflammatory features of experimental migraine, at least partly through mechanisms involving endogenous opioid signaling. These findings suggest enkephalinase inhibition as a promising therapeutic approach for migraine and support further investigation of spinorphin as a potential adjunct to established antimigraine therapies.
- 22 October 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (8)
Spinorphin Ameliorates Nitroglycerin‐Induced Migraine‐Like Responses and Trigeminovascular Neuroinflammation Potentially Through Opioid Receptor‐Mediated Mechanisms
Enhancement of endogenous opioid signaling through inhibition of enkephalin degradation has emerged as a potential strategy for pain control, yet its role in migraine remains unclear. This study investigated whether spinorphin, an endogenous inhibitor of multiple enkephalinases, attenuates trigeminovascular activation and migraine‐like responses in experimental migraine. Migraine‐like pain was induced in male Wistar rats by nitroglycerin. The effects of spinorphin were evaluated using periorbital and plantar von Frey tests, followed by assessment of c‐Fos levels in the trigeminal nucleus caudalis (TNC), calcitonin gene‐related peptide (CGRP) levels in the trigeminal ganglion (TG) and TNC, and meningeal mast cell degranulation. Opioid receptor involvement was examined using nalmefene. In complementary ex vivo hemiskull preparations, capsaicin‐evoked CGRP release was quantified, and the interaction between spinorphin and sumatriptan was investigated. Spinorphin dose‐dependently alleviated cephalic and extracephalic mechanical hypersensitivity, reduced c‐Fos levels, decreased CGRP concentrations in the TG and TNC, and inhibited meningeal mast cell degranulation. These protective effects were markedly attenuated by nalmefene, supporting the involvement of opioid receptor‐mediated mechanisms. In ex vivo preparations, spinorphin selectively reduced capsaicin‐induced CGRP levels in the superfusates without affecting basal CGRP levels, and this effect was abolished by nalmefene. Moreover, spinorphin enhanced the inhibitory effect of sumatriptan on capsaicin‐stimulated CGRP levels. Spinorphin attenuates behavioral, neurochemical, and neuroinflammatory features of experimental migraine, at least partly through mechanisms involving endogenous opioid signaling. These findings suggest enkephalinase inhibition as a promising therapeutic approach for migraine and support further investigation of spinorphin as a potential adjunct to established antimigraine therapies.
- Open Access
- 12 February 2026
- Published by Academician Publishing
Biyofiziksel Perspektifle Fizik Tedavi Modaliteleri
- 12 February 2026
- Published by Academician Publishing
Open AccessBiyofiziksel Perspektifle Fizik Tedavi Modaliteleri
- 12 February 2026
- Published by Academician Publishing
- p. 83-92
Transkutanöz Elektriksel Sinir Stimülasyonu (Tens)
Transkutanöz elektriksel sinir stimülasyonu (TENS) uzun zamandır ağrının tedavisinde kullanılan bir fizik tedavi modalitesidir. TENS aygıtı ile oluşturulan belirli parametrelerdeki alçak frekanslı alternatif akım cilde yerleştirilen elektrotlar vasıtasıyla uygulanmaktadır. Etki mekanizması kapı kontrol teorisi, endojen opioid sistem aktivasyonu, çeşitli nörotransmitter ve reseptörlerin aracılık ettiği santral ve periferik mekanizmalar ile açıklanmaktadır. Kapı kontrol teorisi bunlar içerisinde en çok kabul gören mekanizmadır. Uygulanan TENS türüne göre faklı mekanizmalar devreye girerek analjeziyi sağlayabilir.
- 12 February 2026
- Published by Academician Publishing
- p. 83-92
Transkutanöz Elektriksel Sinir Stimülasyonu (Tens)
Transkutanöz elektriksel sinir stimülasyonu (TENS) uzun zamandır ağrının tedavisinde kullanılan bir fizik tedavi modalitesidir. TENS aygıtı ile oluşturulan belirli parametrelerdeki alçak frekanslı alternatif akım cilde yerleştirilen elektrotlar vasıtasıyla uygulanmaktadır. Etki mekanizması kapı kontrol teorisi, endojen opioid sistem aktivasyonu, çeşitli nörotransmitter ve reseptörlerin aracılık ettiği santral ve periferik mekanizmalar ile açıklanmaktadır. Kapı kontrol teorisi bunlar içerisinde en çok kabul gören mekanizmadır. Uygulanan TENS türüne göre faklı mekanizmalar devreye girerek analjeziyi sağlayabilir.
- 30 June 2022
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 12 (2) , 294-301
Increased Systemic Inflammatory Response with Mast Cell Activation In Elder Children With Cerebral Palsy
Objective: Increased systemic inflammatory response during intrauterine period or period before the age of 3 is associated with cerebral palsy (CP) pathogenesis; however, effects of inflammatory processes involving mast cell activation in elder children with CP remain unclear. We aimed to investigate the role of mast cells and proinflammatory cytokines in children with CP at 3-18 years of age. Methods: In this cross-sectional study, venous blood samples were obtained from 30 volunteers with CP and 26 healthy volunteers at 3-18 years of age. Plasma levels of proinflammatory cytokines (IL-1β, IL-6 and IL-9) and mast cell biomarkers (histamine and tryptase beta-2) were determined using ELISA. Results: IL-1β, IL-6 and histamine levels were higher in individuals with CP compared to healthy controls. Likewise, IL-1β, IL-6, IL-9 and histamine levels were higher in the female patients with CP compared to the male patients, and in the female patients in adolescence compared to the female patients in pre-adolescence. Conclusion: Our findings indicate that the increased inflammatory response contributes to the pathogenesis of the disease in children with CP who are older than 2 years of age. Moreover the increased inflammatory response is more effective in female patients than in male patients, suggesting that there may be a gender difference in CP. Additionally mast cell activation contributes to the exacerbation of systemic inflammatory response in children with CP at 3-18 years of age.
- 30 June 2022
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 12 (2) , 294-301
Increased Systemic Inflammatory Response with Mast Cell Activation In Elder Children With Cerebral Palsy
Objective: Increased systemic inflammatory response during intrauterine period or period before the age of 3 is associated with cerebral palsy (CP) pathogenesis; however, effects of inflammatory processes involving mast cell activation in elder children with CP remain unclear. We aimed to investigate the role of mast cells and proinflammatory cytokines in children with CP at 3-18 years of age. Methods: In this cross-sectional study, venous blood samples were obtained from 30 volunteers with CP and 26 healthy volunteers at 3-18 years of age. Plasma levels of proinflammatory cytokines (IL-1β, IL-6 and IL-9) and mast cell biomarkers (histamine and tryptase beta-2) were determined using ELISA. Results: IL-1β, IL-6 and histamine levels were higher in individuals with CP compared to healthy controls. Likewise, IL-1β, IL-6, IL-9 and histamine levels were higher in the female patients with CP compared to the male patients, and in the female patients in adolescence compared to the female patients in pre-adolescence. Conclusion: Our findings indicate that the increased inflammatory response contributes to the pathogenesis of the disease in children with CP who are older than 2 years of age. Moreover the increased inflammatory response is more effective in female patients than in male patients, suggesting that there may be a gender difference in CP. Additionally mast cell activation contributes to the exacerbation of systemic inflammatory response in children with CP at 3-18 years of age.